{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:38:03Z","timestamp":1782758283315,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12987-016-0049-7","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T06:37:35Z","timestamp":1484807855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The MRZ reaction in primary progressive multiple sclerosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Tilman","family":"Hottenrott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Dersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Huzly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Stich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"49_CR1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46:907\u201311.","journal-title":"Neurology"},{"key":"49_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/brain\/116.1.117","volume":"116","author":"B Runmarker","year":"1993","unstructured":"Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993;116:117\u201334.","journal-title":"Brain"},{"key":"49_CR3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-0953-0","volume":"123","author":"J Antel","year":"2012","unstructured":"Antel J, Antel S, Caramanos Z, et al. Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol. 2012;123:627\u201338.","journal-title":"Acta Neuropathol"},{"key":"49_CR4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol"},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF00422934","volume":"70","author":"K Felgenhauer","year":"1992","unstructured":"Felgenhauer K, Reiber H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin Investig. 1992;70:28\u201337.","journal-title":"Clin Investig"},{"key":"49_CR6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.410320317","volume":"32","author":"MS Godec","year":"1992","unstructured":"Godec MS, Asher DM, Murray RS, et al. Absence of measles, mumps, and rubella viral genomic sequences from multiple sclerosis brain tissue by polymerase chain reaction. Ann Neurol. 1992;32:401\u20134.","journal-title":"Ann Neurol"},{"key":"49_CR7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/jnnp.2007.133330","volume":"79","author":"S Jarius","year":"2008","unstructured":"Jarius S, Franciotta D, Bergamaschi R, et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2008;79:1134\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"49_CR8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jns.2008.08.002","volume":"280","author":"S Jarius","year":"2009","unstructured":"Jarius S, Eichhorn P, Jacobi C, et al. The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity? J Neurol Sci. 2009;280:98\u2013100.","journal-title":"J Neurol Sci"},{"key":"49_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12987-015-0024-8","volume":"12","author":"T Hottenrott","year":"2015","unstructured":"Hottenrott T, Dersch R, Berger B, et al. The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort. Fluids Barriers CNS. 2015;12:27.","journal-title":"Fluids Barriers CNS"},{"key":"49_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-0404.2005.00418.x","volume":"112","author":"J Bednarova","year":"2005","unstructured":"Bednarova J, Stourac P, Adam P. Relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurol Scand. 2005;112:97\u2013102.","journal-title":"Acta Neurol Scand"},{"key":"49_CR11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1590\/S0004-282X1995000500008","volume":"53","author":"M Puccioni-Sohler","year":"1995","unstructured":"Puccioni-Sohler M, Kitze B, Felgenhauer K, et al. The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis. Arq Neuropsiquiatr. 1995;53:760\u20135.","journal-title":"Arq Neuropsiquiatr"},{"key":"49_CR12","doi-asserted-by":"crossref","first-page":"e7638","DOI":"10.1371\/journal.pone.0007638","volume":"4","author":"J Brettschneider","year":"2009","unstructured":"Brettschneider J, Tumani H, Kiechle U, et al. IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS ONE. 2009;4:e7638.","journal-title":"PLoS ONE"},{"key":"49_CR13","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73:1914\u201322.","journal-title":"Neurology"},{"key":"49_CR14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","volume":"37","author":"H Reiber","year":"1991","unstructured":"Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem. 1991;37:1153\u201360.","journal-title":"Clin Chem"},{"key":"49_CR15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/135245859800400304","volume":"4","author":"H Reiber","year":"1998","unstructured":"Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler. 1998;4:111\u20137.","journal-title":"Mult Scler"},{"key":"49_CR16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"M Andersson","year":"1994","unstructured":"Andersson M, Alvarez-Cerme\u00f1o J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994;57:897\u2013902.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"49_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12350","author":"O Stich","year":"2014","unstructured":"Stich O, Kluge J, Speck J, et al. Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients. Acta Neurol Scand. 2014;. doi: 10.1111\/ane.12350 .","journal-title":"Acta Neurol Scand"},{"key":"49_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/brain\/122.4.625","volume":"122","author":"DA Cottrell","year":"1999","unstructured":"Cottrell DA, Kremenchutzky M, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain. 1999;122:625\u201339.","journal-title":"Brain"},{"key":"49_CR19","doi-asserted-by":"crossref","first-page":"e40431","DOI":"10.1371\/journal.pone.0040431","volume":"7","author":"I Brecht","year":"2012","unstructured":"Brecht I, Weissbrich B, Braun J, et al. Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. PLoS ONE. 2012;7:e40431.","journal-title":"PLoS ONE"},{"key":"49_CR20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","volume":"67","author":"LI Levin","year":"2010","unstructured":"Levin LI, Munger KL, O\u2019Reilly EJ, et al. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol. 2010;67:824\u201330.","journal-title":"Ann Neurol"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0404.2006.00755.x","volume":"115","author":"M Robinson-Agramonte","year":"2007","unstructured":"Robinson-Agramonte M, Reiber H, Cabrera-Gomez JA, et al. Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients. Acta Neurol Scand. 2007;115:312\u20138.","journal-title":"Acta Neurol Scand"},{"key":"49_CR22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ymeth.2012.03.002","volume":"56","author":"A Ku\u0142akowska","year":"2012","unstructured":"Ku\u0142akowska A, Mroczko B, Mantur M, et al. Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis. Methods. 2012;56:528\u201331.","journal-title":"Methods"},{"key":"49_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(97)00272-4","volume":"155","author":"H Tumani","year":"1998","unstructured":"Tumani H, Tourtellotte WW, Peter JB, et al. Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group. J Neurol Sci. 1998;155:44\u20139.","journal-title":"J Neurol Sci"},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"e28094","DOI":"10.1371\/journal.pone.0028094","volume":"7","author":"B Rosche","year":"2012","unstructured":"Rosche B, Laurent S, Conradi S, et al. Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis. PLoS ONE. 2012;7:e28094.","journal-title":"PLoS ONE"},{"key":"49_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2008.12.029","volume":"279","author":"S Siritho","year":"2009","unstructured":"Siritho S, Freedman MS. The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci. 2009;279:21\u20135.","journal-title":"J Neurol Sci"},{"key":"49_CR26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","volume":"13","author":"F Deisenhammer","year":"2006","unstructured":"Deisenhammer F, Bartos A, Egg R, et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol. 2006;13:913\u201322.","journal-title":"Eur J Neurol"},{"key":"49_CR27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.22508","volume":"70","author":"H Tumani","year":"2011","unstructured":"Tumani H, Deisenhammer F, Giovannoni G, et al. Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis. Ann Neurol. 2011;70:520 (author reply 521).","journal-title":"Ann Neurol"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-016-0049-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T22:16:33Z","timestamp":1719008193000},"score":1,"resource":{"primary":{"URL":"http:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-016-0049-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1186\/s12987-016-0049-7","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]},"article-number":"2"}}